As shown in Table 2, detailed analyses revealed that expression of TBLR1was significantly associated with clinical stage (P <0.001), tumor (T) classification (P <0.001), node (N) classification (P = 0.024), metastasis (M) classification (P = 0.004), pathological differentiation (P = 0.044), c-erbB-2 expression (P = 0.036) and Ki-67 expression (P <0.001). Here, MKI67 is linked to neoplasm.